首页> 外文期刊>The American Journal of Human Genetics >Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer.
【24h】

Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer.

机译:表面活性剂蛋白A2的遗传缺陷与肺纤维化和肺癌有关。

获取原文
获取原文并翻译 | 示例
           

摘要

Idiopathic pulmonary fibrosis (IPF) is a lethal scarring lung disease that affects older adults. Heterozygous rare mutations in the genes encoding telomerase are found in approximately 15% of familial cases. We have used linkage to map another disease-causing gene in a large family with IPF and adenocarcinoma of the lung to a 15.7 Mb region on chromosome 10. We identified a rare missense mutation in a candidate gene, SFTPA2, within the interval encoding surfactant protein A2 (SP-A2). Another rare mutation in SFTPA2 was identified in another family with IPF and lung cancer. Both mutations involve invariant residues in the highly conserved carbohydrate-recognition domain of the protein and are predicted to disrupt protein structure. Recombinant proteins carrying these mutations are retained in the endoplasmic reticulum and are not secreted. These data are consistent with SFTPA2 germline mutations that interfere with protein trafficking and cause familial IPF and lung cancer.
机译:特发性肺纤维化(IPF)是一种致命的疤痕性肺病,影响老年人。在大约15%的家族性病例中发现了编码端粒酶的基因中的杂合罕见突变。我们已使用连锁关系将IPF和肺腺癌大家族中的另一个致病基因定位到10号染色体上的15.7 Mb区域。我们在编码表面活性剂蛋白的间隔内鉴定了候选基因SFTPA2中的罕见错义突变A2(SP-A2)。在另一个患有IPF和肺癌的家庭中发现了SFTPA2的另一个罕见突变。两种突变都涉及蛋白质高度保守的碳水化合物识别结构域中的恒定残基,并且预计会破坏蛋白质结构。携带这些突变的重组蛋白保留在内质网中,不会被分泌。这些数据与SFTPA2种系突变相一致,后者干扰蛋白质运输并引起家族性IPF和肺癌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号